Statera Biopharma, Inc. Proceeds from Long-Term Debt Issued
Statera Biopharma, Inc. reported Proceeds from Long-Term Debt Issued of $500.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2022-11-14
- Statera Biopharma, Inc. proceeds from issuance of long-term debt for the quarter ending 2022-09-30 was $0.00.
- Statera Biopharma, Inc. proceeds from issuance of long-term debt for the quarter ending 2021-09-30 was -$200.00K.
- Statera Biopharma, Inc. proceeds from issuance of long-term debt for the quarter ending 2013-12-31 was $30.00K.
- Statera Biopharma, Inc. proceeds from issuance of long-term debt for fiscal 2013 was $7.33M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $500.00K 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $500.00K 10-Q · filed 2022-10-28 | |||
| 2021-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $14.67M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $14.87M 10-Q · filed 2022-10-28 | |||
| 2013-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $7.33M 10-K · filed 2014-03-17 | ||
| 2013-09-30 | $7.30M 10-Q · filed 2013-11-08 |